Recent Developments in Contrast Media

Over the past decade, several clinical studies have shown gadolinium-based magnetic resonance imaging (MRI) contrast agents accumulate in tissues inside patients. This has raised concern because prolonged, elevated levels of gadolinium in the body may cause a nephrogenic systemic fibrosis in patients with severe kidney disease. Adding to this concern were three studies in 2015, which raised new gadolinium safety concerns after it was found the agent also accumulates in the brain

Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma, Journal of Nanobiotechnology

Life Sciences on X: Development of contrast media for magnetic resonance imaging / X

Switch to MR Angiography for PE Mitigated Impact of Recent Contrast Shortage

Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent

Iodinated contrast use before, during and after COVID: Trends predict significant growth in demand

Recent advances in the preclinical development of responsive MRI contrast agents capable of detecting hydrogen peroxide - ScienceDirect

Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma, Journal of Nanobiotechnology

Recent Developments and Issues in Contrast Media

Contrast Agents for MRI: Experimental Methods (ISSN) eBook : Pierre, Valérie C, Allen, Matthew J, Kovács, Zoltán, Tircsó, Gyula, Helm, Lothar, Botta, Mauro, Morrow, Janet, Platas-Inglesias, Carlos, Scholl, Timothy, Bartha, Robert